Maatougui Jasser¹*, Raboudi Mehdi¹, Ben Rejeb Nedhir¹, Besrour Chayma^1,2, Gargouri Faten³, Ramzi Khiari¹, Ouertani Haroun² and Ghozzi Samir¹

¹Department of Urology, Military Hospital of Tunis, Tunis, Tunisia
²Department of Endocrinology, Military Hospital of Tunis, Tunis, Tunisia
³Department of Pathology, Military Hospital of Tunis, Tunis, Tunisia

*Corresponding Author: Maatougui Jasser, Department of Urology, Military Hospital of Tunis, Tunis, Tunisia.

Received: November 22, 2021; Published: December 15, 2021

Abstract

Adrenocortical carcinoma is a rare entity. We report a case of a 47-year-old male with abdominal pain. without classical tumor symptoms. Computed tomography revealed a left adrenal mass measuring 17 cm. Hormonal evaluation was negative. Open left adrenalectomy was performed by sub-costal approach. Diagnosis of adrenocortical carcinoma was established by pathology. Metastatic workup was negative. The patient has been followed regularly with no recurrence for one year. Adrenocortical carcinoma is a challenge. Surgery is the main treatment.

Keywords: Adrenocortical Carcinoma; Adrenalectomy; Mitotane

References

1. Almarzouq A., et al. “Giant nonfunctioning adrenocortical carcinoma: a case report and review of the literature”. BMC Research Notes 31 (2014): 7.
2. Patel VV., et al. “Giant non-functioning adrenocortical carcinoma: A rare childhood tumor”. Indian Journal of Medical and Paediatric Oncology 2 (2010): 65-68.
3. Vassilopoulou-Sellin R and Schultz PN. “Adrenocortical carcinoma. Clinical outcome at the end of the 20^th century”. Cancer 92 (2021): 1113.
4. Dehner LP and Hill DA. “Adrenal cortical neoplasms in children: Why so many carcinomas and yet so many survivors?” Pediatric and Developmental Pathology 12 (2009): 284-291.
5. Angeli A., et al. “Adrenal incidentaloma: An overview of clinical and epidemiological data from the National Italian Study Group”. Hormone Research 47 (1997): 279-283.
6. Kapoor A., et al. “Guidelines for the Management of the Incidentally Discovered Adrenal Mass”. Canadian Urological Association Journal 4 (2011): 241-247.
7. Zhou Z., et al. “Multidisciplinary team therapy for left giant adrenocortical carcinoma: A case report”. World Journal of Clinical Cases 20 (2021): 5737-5743.
8. Schteingart DE., et al. “Management of patients with adrenal cancer: recommendations of an international consensus conference”. Endocrine-Related Cancer 12 (2005): 667.
9. Kiesewetter B., et al. “Management of adrenocortical carcinoma: are we making progress?”. Therapeutic Advances in Medical Oncology 13 (2021): 17588359211038409.
10. Mytareli C., et al. “The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review”. Biomedicines 11 (2021): 1501.

Citation

Citation: Maatougui Jasser., et al. “Huge Adrenocortical Carcinoma: Case Report and Literature Review”.Acta Scientific Medical Sciences 6.1 (2022): 151-153.